Triplet therapy with BRAF inhibitor, anti-EGFR agent, and MEK inhibitor in V600E BRAF–mutant colorectal cancer: A meta-analysis.

Authors: Michela Guardascione, Fabiola Giudici, Paola Di Nardo, Simone Rota, Riccardo Vida, Elena Ongaro, Arianna Fumagalli, Marco de Scordilli, Luisa Foltran, Fabio Puglisi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15558

Source: Full article

---

Abstract

e15558